SCHEMBL3718155

SCHEMBL3718155

CCCC(C)C(=O)N1CCCC(C(=O)O)C1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
ACE P12821 3/20 0.44
REN P00797 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
PRSS1 P07477 2/20 0.43
TMPRSS15 P98073 2/20 0.43
LMNA P02545 1/20 0.43
XPNPEP2 O43895 1/20 0.42
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
EPHX2 P34913 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24447495 0.84 DPP4 (0.51) SMN1; SMN2ACEALDH1A1MAPK1LMNA
SCHEMBL12430299 0.82 ALDH1A1 (0.46) SMN1; SMN2ACERENALDH1A1MAPK1
SCHEMBL20839141 0.81 ALDH1A1 (0.45) SMN1; SMN2ACERENALDH1A1MAPK1
SCHEMBL20839142 0.81 ALDH1A1 (0.45) SMN1; SMN2ACERENALDH1A1MAPK1
SCHEMBL23241332 0.80 L3MBTL1 (0.44) ALDH1A1GAACYP2C19EPHX2
SCHEMBL8498746 0.80 L3MBTL1 (0.44) ALDH1A1GAACYP2C19EPHX2
SCHEMBL22991239 0.80 ALDH1A1 (0.44) SMN1; SMN2ACERENALDH1A1MAPK1
SCHEMBL13003486 0.78 L3MBTL1 (0.42) GAACYP2C19HPGDEPHX2
SCHEMBL8177559 0.78 HPGD (0.52) SMN1; SMN2ALDH1A1NPC1HPGDTSHR
SCHEMBL6954395 0.78 XPNPEP2 (0.43) SMN1; SMN2ACEALDH1A1MAPK1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718628-B2 SREBP inhibitors comprising a 6-membered central ring CAPULUS THERAPEUTICS, LLC (US) 2023-08-08 US disclosed
US-20210047340-A1 SREBP INHIBITORS COMPRISING A 6-MEMBERED CENTRAL RING CAPULUS THERAPEUTICS, LLC 2021-02-18 US disclosed
EP-2614826-B1 Process for preparation of thiazole derivatives DOW AGROSCIENCES LLC (US) 2017-03-01 EP disclosed
US-9357780-B2 Pesticidal compositions DOW AGROSCIENCES LLC (US) 2016-06-07 US disclosed
EP-2614825-B1 Process for the preparation of thiazole derivatives DOW AGROSCIENCES LLC (US) 2016-03-16 EP disclosed
EP-2427191-B1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2016-03-16 EP disclosed
EP-2604267-B1 Process for the preparation of thiazole derivatives DOW AGROSCIENCES LLC (US) 2016-02-03 EP disclosed
CN-105017240-A Pesticidal compositions DOW AGROSCIENCES LLC 2015-11-04 CN disclosed
EP-2604268-B1 Process for the preparation of thiazole derivatives DOW AGROSCIENCES LLC (US) 2015-09-16 EP disclosed
CN-102458403-B Insecticidal composition DOW AGROSCIENCES LLC 2015-06-03 CN disclosed
EP-2614825-A1 Process for the preparation of thiazole derivatives Dow AgroSciences LLC (US) 2013-07-17 EP disclosed
EP-2614826-A1 Process for preparation of thiazole derivatives Dow AgroSciences LLC (US) 2013-07-17 EP disclosed
EP-2604267-A1 Process for the preparation of thiazole derivatives Dow AgroSciences LLC (US) 2013-06-19 EP disclosed
EP-2604268-A1 Process for the preparation of thiazole derivatives Dow AgroSciences LLC (US) 2013-06-19 EP disclosed
US-20130089622-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2013-04-11 US disclosed
US-20130072382-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2013-03-21 US disclosed
US-8350044-B2 Pesticidal compositions DOW AGROSCIENCES, LLC. (US) 2013-01-08 US disclosed
CN-102458403-A insecticidal composition DOW AGROSCIENCES LLC 2012-05-16 CN disclosed
US-20100292253-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2010-11-18 US disclosed
WO-2010129497-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718628-B2 SREBP inhibitors comprising a 6-membered central ring SREBF1, SREBF2, XBP1 SMN1; SMN2 4012/4885ACE 948/4885REN 986/4885
US-20210047340-A1 SREBP INHIBITORS COMPRISING A 6-MEMBERED CENTRAL RING SREBF1, SREBF2, XBP1 SMN1; SMN2 4012/4885ACE 948/4885REN 986/4885
US-20100292253-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, PRDX6 SMN1; SMN2 2870/4885ACE 1222/4885REN 1167/4885
US-20130089622-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, PRDX6 SMN1; SMN2 2870/4885ACE 1222/4885REN 1167/4885
US-20130072382-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, PRDX6 SMN1; SMN2 2870/4885ACE 1222/4885REN 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.